Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 5/20 | 0.66 |
| ▸ | ESR2 | Q92731 | 4/20 | 0.66 |
| ▸ | TTR | P02766 | 1/20 | 0.48 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.48 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.48 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.48 |
| ▸ | CYTH2 | Q99418 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
| ▸ | PKM | P14618 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | CNR1 | P21554 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30899192 | 0.92 | ESR2 (0.74) | ESR1ESR2TTRALOX5PTGS1 | |
| SCHEMBL2618675 | 0.89 | ESR1 (0.55) | ESR1ESR2TTRALOX5PTGS1 | |
| SCHEMBL455094 | 0.86 | CA2 (0.55) | ESR1ESR2TTRALOX5PTGS1 | |
| SCHEMBL5086131 | 0.85 | ESR1 (0.69) | ESR1ESR2TTRALOX5PTGS1 | |
| SCHEMBL23861509 | 0.85 | ESR2 (0.54) | ESR1ESR2TTRALOX5PTGS1 | |
| SCHEMBL17273215 | 0.84 | ESR1 (0.53) | ESR1ESR2TTRALOX5PTGS1 | |
| SCHEMBL8349499 | 0.84 | ESR1 (0.53) | ESR1ESR2TTRALOX5PTGS1 | |
| SCHEMBL8407830 | 0.84 | CA2 (0.52) | ESR1ESR2TTRALOX5PTGS1 | |
| SCHEMBL23861357 | 0.83 | ESR1 (0.60) | ESR1ESR2ALDH1A1CYP3A4KMT2A | |
| SCHEMBL13609942 | 0.83 | ESR1 (0.59) | ESR1ESR2ALDH1A1CYP3A4CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 220 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7671167-B2 | Poly(arylene ether) copolymer | SABIC INNOVATIVE PLASTICS IP B.V. (NL) | 2010-03-02 | — | — | US | claimed |
| US-20090247724-A1 | POLY(ARYLENE ETHER) COPOLYMER | SHPP GLOBAL TECHNOLOGIES B.V. (NL) | 2009-10-01 | — | — | US | claimed |
| EP-1969030-A2 | POLY (ARYLENE ETHER) COPOLYMER | GENERAL ELECTRIC COMPANY (US) | 2008-09-17 | — | — | EP | claimed |
| WO-2007067669-A2 | POLY (ARYLENE ETHER) COPOLYMER | GENERAL ELECTRIC COMPANY (US) | 2007-06-14 | — | — | WO | claimed |
| US-20070135609-A1 | Poly(arylene ether) copolymer | SHPP GLOBAL TECHNOLOGIES B.V. (NL) | 2007-06-14 | — | — | US | claimed |
| US-20070106051-A1 | Polyfunctional poly(arylene ether) method | CITIBANK, N.A., AS COLLATERAL AGENT | 2007-05-10 | — | — | US | claimed |
| US-20260132242-A1 | CURABLE RESIN, CURABLE RESIN COMPOSITION, AND CURED PRODUCT | DIC CORPORATION (JP) | 2026-05-14 | — | — | US | disclosed |
| EP-3636692-B1 | POLY(ARYLENE ETHER) COPOLYMER | SHPP GLOBAL TECH BV (NL) | 2026-04-29 | — | — | EP | disclosed |
| US-12600856-B2 | Resin composition, formed article, and, formed article with hard coat layer | MITSUBISHI CHEMICAL CORPORATION (JP) | 2026-04-14 | — | — | US | disclosed |
| US-20260071104-A1 | Anionic Curable Compositions | DESIGNER MOLECULES INC (US) | 2026-03-12 | — | — | US | disclosed |
| US-20260071103-A1 | Anionic Curable Compositions | DESIGNER MOLECULES INC (US) | 2026-03-12 | — | — | US | disclosed |
| US-12503593-B2 | Curable thermosetting composition including poly(arylene ether) copolymer | SHPP GLOBAL TECHNOLOGIES B.V. (NL) | 2025-12-23 | — | — | US | disclosed |
| WO-2025224626-A1 | THERMOPLASTIC POLYURETHANE AND ASSOCIATED METHOD AND ARTICLE | SHPP GLOBAL TECHNOLOGIES B.V. (NL) | 2025-10-30 | — | — | WO | disclosed |
| EP-0768155-A1 | Process for making thermoplastic granules from polymer solutions | BAYER AG (DE) | 1997-04-16 | — | — | EP | disclosed |
| EP-0747749-A1 | ELECTRODE PLATE FOR LIQUID CRYSTAL | KANEGAFUCHI KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1996-12-11 | — | — | EP | disclosed |
| EP-0742260-A1 | (Co)polycarbonates stabilized against gamma-rays | BAYER AG (DE) | 1996-11-13 | — | — | EP | disclosed |
| EP-0732365-A1 | Polycarbonate compositions resistant to gamma radiation | BAYER AG (DE) | 1996-09-18 | — | — | EP | disclosed |
| EP-0402729-B1 | Polycarbonates having vinylaromatic endgroup | BAYER AG (DE) | 1995-03-01 | — | — | EP | disclosed |
| EP-0500131-A2 | Polycarbonate resin solution for film formation by casting | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 1992-08-26 | — | — | EP | disclosed |
| US-4956485-A | Trialkylsilyloxy-1,1-diphenyl ethylenes and polymers produced therewith | BAYER AKTIENGESELLSCHAFT (DE) | 1990-09-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260071104-A1 | Anionic Curable Compositions | VCL, ITGA8, GABRE | ESR1 467/4885ESR2 1403/4885TTR 2823/4885 |
| US-20260132242-A1 | CURABLE RESIN, CURABLE RESIN COMPOSITION, AND CURED PRODUCT | ASH2L, ARL1, CARM1 | ESR1 2826/4885ESR2 1296/4885TTR 2928/4885 |
| US-20260071103-A1 | Anionic Curable Compositions | CDH1, ESD, SETD2 | ESR1 669/4885ESR2 1338/4885TTR 3907/4885 |
| US-12600856-B2 | Resin composition, formed article, and, formed article with hard coat layer | ARID2, ASH2L, COL2A1 | ESR1 3195/4885ESR2 1945/4885TTR 1626/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.